April 2010

You are currently browsing the monthly archive for April 2010.

My paper on how physician compensation affects surgery rates is being published in the May 2010 edition of Health Economics.  The abstract from the article is below:

This paper employs a nationally representative, household-based dataset in order to test how the compensation method of both the specialists and the primary care providers affects surgery rates. After controlling for adverse selection, I find that when specialists are paid through a fee-for-system scheme rather than on a capitation basis, surgery rates increase 78%. The impact of primary care physician compensation on surgery rates depends on whether or not referral restrictions are present.

Tags: ,

One of the first steps after the passage of health reform is the creation of a high risk pool for uninsured individuals.  This is help individuals such as 56 year old Laura Carpenter of Tuolumne, CA.  Individuals such as With the $5 billion allocated for this task, Health and Human Services (HHS) Secretary Kathleen Sebelius sent the following letter to U.S. governors:

“The establishment of a temporary new high risk pool program is one of our first tasks in implementing the new health reform law and will help provide affordable insurance for Americans who have been locked out of the insurance market for too long,” said Sebelius. “This letter marks the first step in that process and demonstrates one of our core principles of implementation — building on effective programs that already exist. In the coming days, we will work closely with states to answer their questions.”

States have 5 options of how they could participate:

  • Operate a new high risk pool alongside a current state high risk pool;
  • Establish a new high risk pool ;
  • Build upon other existing coverage programs designed to cover high risk individuals;
  • Contract with a current HIPAA carrier of last resort; or
  • Do nothing, in which case the federal government through HHS would carry out a coverage program in the state.

Tags: ,

The latest edition of the Cavalcade of Risk is up at Political Calculations.  This edition of the CoR even uses an innovative bond-style rating systems to assist readers (the Healthcare Economist post received a Aa2 rating).

Here are some additional links:

And most importantly, the Milwaukee Bucks make the playoffs!

Tags: ,

In general, I am weary of patents (see my Healthcare Manifesto and Against Intellectual Property posts). Sure, they may be useful to spur innovation, but they also harm innovation since one cannot modify or improve a product while there is still a patent. Further, patents generate rent-seeking where inventors spent tons of time wrangling to secure a patent and less time creating new ideas.

Thus, when I recently saw a 60 Minutes piece which explains that companies could patent genes, I was appalled.  The story centers on a Myriad, a biotech firm with a patent over a gene which predicts breast and ovarian cancer.  Now, I’m not a big fan of patents, but if they do exist, I agree with ACLU lawyer Chris Hansen who said “If Myriad develops a new drug, a new treatment, a new test, they can get a patent and they should be able to get a patent. What they shouldn’t be able to do is get a patent over the gene itself.”

Why does Myriad want to patent the genes?  According to Forbes’ The Business of Science blog, it’s “purely about greed“.

The N.Y. Times reports, however, that the “Federal District Court in Manhattan ruled that the two genes were products of ‘the law of nature,’ and so could not be patented. The judge, Robert W. Sweet, declared that seven patents on the genes, held by Myriad Genetics of Utah, were not valid.”  The title of this article is “Nature, 1; Company, 0,” but a more appropriate title would be “Liberty 1, Monopolies 0″.

Tags: , ,

One aspect of health reform that has received little attention is passage of the Community Living Assistance Services and Supports(CLASS) Act.  This act creates a long-term care (LTC) insurance program.  However, the insurance plan in its current form is fairly limited.  Those who require assistance with activities such as bathing, dressing, getting out of bed and using a toilet would receive about a $50 per day benefit.  This is of course not enough to pay for full-time care in a nursing home, but would help defray some of the cost for assistance in one’s home.

Milliman notes that currently, the CLASS act would be voluntary and would include guarantee issue (meaning that no one could be denied coverage).  Separately, each of these provisions could allow for a sustainable long term care insurance product.  The private sector currently uses the voluntary insurance model with underwriting.  On the other hand, a guaranteed issue policy could work if purchasing LTC insurance was mandatory.

Together, however, these provisions may be problematic.  “The voluntary aspect of the program allows low-risk individuals to never sign up for the program while the guaranteed issues enables some of the highest-risk individuals to join the program.  This is a formula that is virtually certain to create financial instability in any insurance program unless there are other important provisions to control risk.”

The CLASS act does have some additional risk control provisions.  To qualify for these benefits, one must pay into the plan for 5 years.  Employers can decide to offer this LTC as a benefit and employers who choose to this option will have employees automatically enrolled with the premium deducted from each paycheck.  Individuals would have to specifically ask to be removed from the program.  Also, individuals who opt-out of the program will have to pay a higher premium if they decide to opt back in.  The purpose of the vesting and opt-out penalties is to minimize adverse selection.

However, Scot Forman of Long Term Care Associates notes that many employees may not realize that if they opt out after just 1 payment and later opt in more than 5 years in the future, they would pay “a massive penalty,”  If a young worker who has just 1 deduction from her paycheck at age 38 later decides to opt-in when she’s 59, her premiums would be higher than they would have been had she stayed in the program. In the example given, “the rate increase will be no less than 250% on each payment, which is CLASS’s penalty for opting back in.”

Tags: , ,

You feel great.  You exercise regularly, eat well, and have no history of cholesterol problem.  Then you’re just the person who needs Crestor!   Why? Because Crestor not only treat high cholesterol, it also prevents the onset of cholesterol problems!  To keep your heart working as hard as you do, ask your doctor about Crestor.

After a recent FDA ruling, this type of ad may invade your television before too long.  Although Crestor was already approved for the treatment of individuals who have high cholesterol, the FDA recently approved the use of Crestor to prevent the onset of high cholesterol.  The New York Times reports: “Statins have been credited with saving thousands of lives every year with relatively few side effects, and some medical experts endorse the drug’s broader use. But for healthy people who would take statins largely as prevention — which would be the case for the new category of Crestor patients — other experts suggest the benefits may not outweigh any side effects.”

The expansion of the market for Crestor will greatly increase profits for AstraZeneca, just as expanding the market for Fosamax was a boon to the pharmaceutical market.  The question is, will it actually improve patient health?

Tags:

Deciding whether to get tested for genetic diseases is a choice many people will face in the coming years.  By knowing whether or not you are more likely to develop a given disease, you may be able to change your health habits or seek earlier medical treatment.  In addition, genetic testing provides additional knowledge useful in deciding whether or not to purchase long term care insurance.  A paper on Genetic Adverse Selection reveals the following:

…the long-term care insurance ownership rate among those at genetic risk for developing [Huntingon's Disease] (50 percent) is five times the rate of ownership in the general population (10 percent). Furthermore, among individuals whose genetic testing shows that they are 100 percent at risk to develop HD, 50 to 75 percent own insurance…

As more individuals gain private information about the likelihood that they will require costly long-term care, adverse selection may threaten the viability of private long-term care insurance, at least in its present form.

Emily Oster, Ira Shoulson, Kimberly Quaid, E. Ray Dorsey (2009) “Genetic Adverse Selection: Evidence from Long-Term Care Insurance and Huntington Disease,” NBER Working Paper 15326.

Tags: ,

Links

Tags:

Healthcare Technology News has a health reform themed edition of the Health Wonk Review.

Tags:

Because it expands health insurance coverage, one of the key effects of the recently passed health reform bill is that it will decrease the amount of compensated care.  According to an Urban Institute study:

…the cost of uncompensated care will fall from $62.1 billion in 2009 to $46.6 billion in 2019 under the Senate bill, and to $36.5 billion in 2019 with the House bill…Without reform, the cost of uncompensated care will increase to between $107 and $141 billion in 2019, depending on growth in the economy and health care costs.

Who currently pays for uncompensated care?  This chart provides a breakdown.  Surprisingly, physician’s in-kind free treatment makes up only 14% of uncompensated care.  On the other hand, Medicare and Medicaid fund the largest share of uncompensated care.  The reason for this is that Medicare has a disproportionate share hospital (DSH) payment program indirect medical education payments and Medicaid also has a DSH program as well as supplemental provider payments programs.  The authors count these programs as payment for uncompensated care.  The DSH payment system doesn’t make much sense to me.  If, Medicare or Medicaid payments are too low, why not raise the reimbursement rates rather than give lump sum handouts to hospitals in the form of a DSH payment.

State and local government also pay for a large share of uncompensated care.  In California, county-financed clinics are the last refuge for those without insurance, especially for undocumented immigrants.  According to the study, state and local governments pay for about 18% of unfunded care.

Tags: ,

Newer entries »